Bringing the fundamentals into focus…
Back to Grifols, S.A.
How Grifols, S.A. stacks up
GRFS · against 1,336 other Healthcare companies
Valuation
93/ 100
Near the top of its peers.
Ranked #88 of 1,337 · scores higher than 93% of peers
Bars: peers in each 10-point band of the valuation score141 peers with a valuation score of 90–100, including GRFS · Click a bar to see the companies
Why valuation scores 93?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
- Free cash flow yield is not reported, so it is left out of the score.
- more operating profit (EBITDA) for the company's total value: stronger than 85% of peers. EBITDA yield: 11.8% vs peer median 4.0%
- higher earnings for the price paid: stronger than 93% of peers. Earnings yield: 8.8% vs peer median 1.5%
Metric by metric
Position: dot = GRFS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GRFS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 8.8% | 1.5% | 93% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 11.8% | 4.2% | 85% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | Not reported | -1.0% | — | — | 20% |
| Book yieldHigher is better · 1,306 reported | Not reported | 37.9% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around GRFSScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score